ストックスクリーナーアプリを入手
329.82
4.75%
-16.43
アフターアワーズ：
329.57
-0.25
-0.08%
Amgen Inc (AMGN) 最新ニュース
Jennison Associates LLC Sells 91,343 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Margin Expansion In Q1 2026 Tests Cautious Growth Narratives - simplywall.st
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Icon (ICLR) - The Globe and Mail
Amgen Inc. Q1 2026 SEC 10-Q Report: Financial Statements, Defined Terms, and Product Overview 35384155 - Minichart
Amgen Earnings Call Highlights Growth Engines, Tax Risk - TipRanks
Assessing Amgen (AMGN) Valuation After Recent Share Price Weakness And Pipeline Expectations - Yahoo Finance
Amgen Inc (AMGN) Shares Fall 4.8% -- What GF Score of 93 Tells I - GuruFocus
Amgen Inc. stock underperforms Friday when compared to competitors - MSN
AMGN Maintains by Truist Securities -- Price Target Raised to $3 - GuruFocus
Amgen's Shannon Turley Inducted Into National Academy of Sciences - Amgen
Truist Financial Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price - MarketBeat
Amgen: The Quarter Where New Growth Engines Begin to Drown Out the Noise of Patent Expirations - marketscreener.com
Amgen (NASDAQ:AMGN) Shares Gap DownShould You Sell? - MarketBeat
Tranche Update on Amgen Inc.'s Equity Buyback Plan announced on April 21, 2011. - marketscreener.com
Amgen launches late-stage obesity trial in patients who switch from rival drugs - Endpoints News
Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU - Benzinga
IRS Seeks More Taxes From Amgen, Adding to $10.7 Billion Dispute - Bloomberg Law News
Amgen (NASDAQ:AMGN) Price Target Raised to $425.00 - MarketBeat
Amgen's Q1 Earnings Top Estimates, 16 Drugs Deliver Double-Digit Gains - The Globe and Mail
Apple leads Nasdaq higher at open, Amgen drags on Dow - Proactive financial news
Amgen Inc Stock (AMGN) Opened Down by 4.69% on May 1: A Full Analysis - TradingKey
Amgen 1st-qtr 2026 financials beat expectations - The Pharma Letter
Amgen Inc. (NASDAQ:AMGN) Q1 2026 Earnings Call Transcript - Insider Monkey
Nasdaq leads the pack as Apple impresses, Amgen drags on Dow - Yahoo! Finance Canada
Amgen Inc. $AMGN Shares Acquired by Sigma Planning Corp - MarketBeat
New York State Teachers Retirement System Sells 9,158 Shares of Amgen Inc. $AMGN - MarketBeat
BofA Securities raises Amgen stock price target on growth drivers By Investing.com - Investing.com Canada
Strategic Blueprint LLC Lowers Position in Amgen Inc. $AMGN - MarketBeat
Danske Bank A S Decreases Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Fifth Third Bancorp - MarketBeat
Amgen Inc (AMGN) Q1 2026 Earnings Call Highlights: Strong Produc - GuruFocus
Amgen Inc (AMGN) Q1 2026 Earnings Call Highlights: Strong Product Sales Growth Amidst Competitive Challenges - GuruFocus
AMGN Q1 Deep Dive: Growth Drivers Offset Patent Losses, Pipeline Progress in Focus - The Globe and Mail
Amgen (NASDAQ:AMGN) Issues Quarterly Earnings Results - MarketBeat
Amgen : C O R R E C T I O N Amgen/ - marketscreener.com
Amgen Doubles Down On Less Frequent MariTide Maintenance Dosing In Obesity - Citeline News & Insights
Amgen (AMGN) Q1 Earnings Exceed Expectations with Strong Revenue Growth - GuruFocus
Sixteen Amgen drugs posted double-digit sales growth in Q1 - Stock Titan
Amgen (NASDAQ: AMGN) posts Q1 2026 profit of $1.8B amid tax, product risks - Stock Titan
/C O R R E C T I O N -- Amgen/ - PR Newswire
Amgen (AMGN) Q1 2026 Earnings Transcript - AOL.com
Amgen (AMGN) Increases Revenue Projections for FY26 - GuruFocus
Amgen Q1 2026 slides: 16 brands fuel growth despite patent headwinds - Investing.com
Amgen Tops Estimates Despite Mixed Performance of Key Drugs - Bloomberg.com
Amgen Q1 Earnings Call Highlights - MarketBeat
Amgen (AMGN) Reports Strong Q1 Revenue Performance - GuruFocus
Amgen (AMGN) Adjusts Revenue Projections for FY26 Upwards - GuruFocus
Earnings call transcript: Amgen Q1 2026 beats expectations, raises guidance - Investing.com
Amgen sales rise 4% in first quarter, broadens weight-loss drug development - KFGO
Amgen (AMGN) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Earnings call transcript: Amgen Q1 2026 beats expectations, raises guidance By Investing.com - Investing.com Canada
Amgen achieves Q1 double beat; 2026 guidance ranges meet expectations - Seeking Alpha
Transcript: Amgen Q1 2026 Earnings Conference Call - Benzinga
Amgen (AMGN) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
Amgen Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:AMGN) 2026-04-30 - Seeking Alpha
Highlights from Amgen's 2026 First Quarter Earnings Report - Amgen
Amgen beats Q1 earnings and revenue estimates, but shares dip as R&D spend rises - Investing.com Nigeria
FDA Approval for PAVBLU issued to AMGEN INC - Quantisnow
Amgen (NASDAQ:AMGN) Releases FY 2026 Earnings Guidance - MarketBeat
Regeneron Presses Amgen for Eylea Antitrust Damages Evidence - Bloomberg Law News
Amgen’s (NASDAQ:AMGN) Q1 CY2026 Sales Top Estimates - The Globe and Mail
Amgen Posts Higher First-Quarter Profit, Revenue - WSJ
Amgen Q1 Adjusted Earnings, Revenue Rise - marketscreener.com
Earnings Flash (AMGN) Amgen Inc. Reports Q1 Revenue $8.62B, vs. FactSet Est of $8.58B - marketscreener.com
(AMGN) Amgen Expects 2026 Adjusted EPS Range $21.70-$23.10, vs. FactSet Est of $22.16 - marketscreener.com
Earnings Flash (AMGN) Amgen Inc. Posts Q1 Adjusted EPS $5.15 per Share, vs. FactSet Est of $4.77 - marketscreener.com
(AMGN) Amgen Expects 2026 Revenue Range $37.1B-$38.5B, vs. FactSet Est of $37.81B - marketscreener.com
0.62%
1.39%
大文字化:
|
ボリューム (24 時間):